Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Tax Provisions (2018 - 2025)

Marimed (MRMD) has disclosed Tax Provisions for 8 consecutive years, with -$2.7 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 154.3% to -$2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, down 55.95% year-over-year, with the annual reading at $3.6 million for FY2025, 55.95% down from the prior year.
  • Tax Provisions for Q4 2025 was -$2.7 million at Marimed, down from $2.8 million in the prior quarter.
  • The five-year high for Tax Provisions was $7.2 million in Q4 2021, with the low at -$2.7 million in Q4 2025.
  • Average Tax Provisions over 5 years is $2.2 million, with a median of $2.2 million recorded in 2022.
  • The sharpest move saw Tax Provisions soared 9214.56% in 2021, then tumbled 154.3% in 2025.
  • Over 5 years, Tax Provisions stood at $7.2 million in 2021, then plummeted by 127.83% to -$2.0 million in 2022, then soared by 124.97% to $498000.0 in 2023, then skyrocketed by 893.57% to $4.9 million in 2024, then crashed by 154.3% to -$2.7 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at -$2.7 million, $2.8 million, and $691000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.